Piper Sandler Issues Pessimistic Forecast for Vicarious Surgical (NYSE:RBOT) Stock Price

Vicarious Surgical (NYSE:RBOT - Get Free Report) had its price target reduced by investment analysts at Piper Sandler from $10.50 to $8.50 in a research note issued to investors on Tuesday,Benzinga reports. The brokerage currently has a "neutral" rating on the stock. Piper Sandler's target price would suggest a potential upside of 9.25% from the stock's current price.

Vicarious Surgical Trading Down 2.8 %

Shares of RBOT traded down $0.22 during mid-day trading on Tuesday, reaching $7.78. 11,622 shares of the stock traded hands, compared to its average volume of 33,171. Vicarious Surgical has a 1 year low of $4.27 and a 1 year high of $19.00. The company has a market cap of $45.96 million, a price-to-earnings ratio of -0.76 and a beta of 1.35. The firm has a fifty day moving average price of $12.21 and a 200 day moving average price of $10.61.

Vicarious Surgical (NYSE:RBOT - Get Free Report) last posted its earnings results on Monday, March 17th. The company reported ($2.43) EPS for the quarter, topping the consensus estimate of ($2.69) by $0.26. The business had revenue of $2.09 million for the quarter. During the same period last year, the firm posted ($2.25) EPS. On average, sell-side analysts anticipate that Vicarious Surgical will post -10.89 EPS for the current year.

Remove Ads

Institutional Inflows and Outflows

A number of institutional investors have recently added to or reduced their stakes in the company. Renaissance Technologies LLC boosted its holdings in shares of Vicarious Surgical by 11.6% in the 4th quarter. Renaissance Technologies LLC now owns 11,534 shares of the company's stock worth $152,000 after purchasing an additional 1,200 shares in the last quarter. DnB Asset Management AS lifted its position in Vicarious Surgical by 21.1% in the 4th quarter. DnB Asset Management AS now owns 21,213 shares of the company's stock worth $279,000 after buying an additional 3,692 shares during the last quarter. Finally, Geode Capital Management LLC boosted its stake in Vicarious Surgical by 8.2% in the fourth quarter. Geode Capital Management LLC now owns 30,799 shares of the company's stock worth $405,000 after buying an additional 2,336 shares in the last quarter. Institutional investors own 47.27% of the company's stock.

About Vicarious Surgical

Vicarious Surgical Inc operates as a robotics technology company in the United States. The company focuses on developing and commercializing Vicarious System, a single-incision surgical robot that virtually transports surgeons inside the patient to perform minimally invasive surgery. Vicarious Surgical Inc was incorporated in 2014 and is headquartered in Waltham, Massachusetts.